European Medicines Agency recommends licensing Ebola vaccine

NASA Space and Science

LONDON (AP) — The European Medicines Agency has recommended that the world’s first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa.

The agency on Friday described licensing the vaccine as “an important step toward relieving the burden of this deadly disease.” The Ebola vaccine was originally developed in Canada and is now marketed by Merck as Ervebo. More than 270,000 people in Africa have received it as officials try to stop Congo’s ongoing outbreak.

A second vaccine made by Johnson & Johnson, which is not yet licensed, will soon be used in parts of Congo where Ebola is not actively spreading.

Also Friday, the World Health Organization is convening a meeting to consider whether the epidemic in Congo should still be designated a global emergency.

Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Don’t Miss

Join the Pro Football Challenge
Sunday Morning Matters
MedWatch Today
Hispanic Heritage
Bulldog Insider: The Podcast
The Valley's Armenia
Pros Who Know

CBS47 On Your Side

Do you have a problem that you need help solving? Contact Investigative Reporter Erik Rosales and let him be

On Your Side.

Email erikrosales@cbsfresno.com